CERENOVUS Receives European Regulatory Approval For BRAVO Flow Diverter to Treat Intracranial AneurysmsPR-M08-18-NI-088
Novadoz Receives Marketing Approval for Generic Versions of Rosuvastatin, Capecitabine, & MoxifloxacinPR-M08-18-NI-097
Michael Moussourakis is a Director, Technical Marketing and Commercial Development at Alconox, Inc. headquartered in White Plains, NY. The Marketing team provides tactical and product leadership to Alconox, Inc. customers for their critical cleaning needs. He has over 17 years experience in the biotech, pharmaceutical, medical device and laboratory industries. Through various and progressive roles in technical, tactical marketing and product management, he has contributed via publications, training and committee participation. Michael’s technical expertise covers critical cleaning, biopharmaceutical filtration and process troubleshooting. Michael holds a BS and MS in Biomedical Engineering from the Columbia University.